airway
epithelium
critic
interfac
host
environ
common
site
genet
acquir
diseas
state
asthma
chronic
obstruct
pulmonari
diseas
cystic
fibrosi
cf
infecti
diseas
modifi
airway
epithelia
therapeut
protein
gene
express
cassett
genomeedit
reagent
offer
great
promis
efficaci
deliveri
common
challeng
respiratori
epithelium
present
barrier
special
cell
type
secret
host
defens
factor
mucociliari
vivo
deliveri
vector
system
airway
epithelia
remain
poorli
transduc
mani
viral
nonvir
direct
transfer
recombin
protein
promis
altern
use
nucleic
acid
deliv
growth
factor
antivir
crisprassoci
nucleas
ca
ribonucleoprotein
rnp
rnp
compris
ca
nucleas
guid
rna
grna
interest
therapeut
gene
edit
rapid
effect
transient
nucleas
appeal
protein
deliveri
hamper
limit
avail
safe
effect
deliveri
ca
rnp
contain
neg
charg
grna
enabl
deliveri
use
cation
lipid
electropor
respons
cell
howev
protein
green
fluoresc
protein
gfp
antibodi
luciferas
poorli
deliv
use
lack
appropri
biodegrad
difficulti
appli
electropor
limit
option
nonvir
ca
rnp
deliveri
airway
vivo
cellpenetr
peptid
cpp
short
peptid
gener
carri
net
posit
charg
independ
mediat
intern
molecul
across
cell
membran
eg
hiv
tat
human
immunodefici
viru
transact
activ
transcript
howev
cppmediat
deliveri
often
result
limit
cytosol
distribut
due
endosom
sequestr
avoid
endosom
entrap
cpp
may
combin
endosomolyt
peptid
endosom
leakag
domain
bind
transient
destabil
endosom
recent
develop
cppeld
system
vitro
deliveri
protein
ca
rnp
multipl
cell
base
studi
cppeld
peptid
design
addit
peptidebas
agent
term
shuttl
improv
deliveri
ca
rnp
hardtotransduc
human
natur
killer
nk
demonstr
nextgener
shuttl
enabl
protein
transfer
anoth
refractori
cell
type
deliv
report
protein
ca
rnp
vitro
vivo
differenti
epitheli
cell
line
airway
despit
physicochem
barrier
impos
cell
firstgener
shuttl
design
fuse
endosomolyt
peptid
cpp
sixhistidin
tag
one
end
peptid
activ
construct
demonstr
deliv
differ
protein
cargo
multipl
cell
type
modifi
peptid
sequenc
increas
deliveri
present
subset
three
ration
design
peptid
term
figur
show
peptid
sequenc
align
peptid
share
featur
includ
improv
hydrophob
cluster
deriv
domain
optim
hydrophiliccation
tail
deriv
cellpenetr
peptid
diverg
other
addit
variabl
length
amino
acid
contain
five
highli
hydrophob
residu
domain
eight
linker
reduc
singl
glycin
domain
contain
six
cation
residu
compar
four
use
three
ration
design
peptid
demonstr
improv
edit
nk
cell
coincub
rnp
figur
present
edit
measur
locu
follow
rnp
deliveri
nk
cell
rnp
deliveri
improv
edit
achiev
indel
respect
compar
previous
report
enabl
shuttl
peptid
enabl
rnp
deliveri
nk
cell
hypothes
could
deliv
protein
ca
rnp
hardtotransduc
welldifferenti
primari
cultur
human
airway
epitheli
hae
cell
fig
differ
peptid
length
hydrophob
linker
charg
may
influenc
deliveri
effici
appli
new
cell
type
first
test
feasibl
peptidemedi
deliveri
hae
use
gfp
protein
shuttl
peptid
combin
recombin
nucleartarget
gfp
protein
appli
apic
surfac
min
gfp
signal
quantifi
fluoresc
imag
fig
left
panel
concentr
achiev
greatest
gfp
deliveri
en
face
imag
demonstr
gfp
signal
throughout
epithelium
fig
right
panel
similar
result
obtain
four
shuttl
peptid
use
transfer
gfp
protein
primari
cultur
porcin
tracheal
epithelia
larg
anim
model
supplementari
fig
identifi
cell
type
transduc
human
airway
epithelia
coloc
gfp
specif
cell
type
marker
fifteen
minut
appli
gfp
observ
gfpposit
gfp
nuclei
cell
posit
acetyl
ciliat
cell
marker
fig
left
panel
white
arrow
gfp
also
coloc
noncili
cell
fig
left
panel
white
arrowhead
marker
goblet
secretori
cell
fig
right
panel
white
arrowhead
morphometr
analysi
transduct
effici
rang
cell
type
surfac
epithelium
mean
se
n
also
appli
peptid
gfp
apic
surfac
freshli
excis
human
tracheal
tissu
explant
one
hour
later
gfp
nuclei
coloc
ciliat
noncili
surfac
epithelia
fig
proof
principl
deliv
rnp
target
cftr
intron
hae
noncf
donor
four
shuttl
peptid
use
deliv
gfp
intron
region
site
cftr
splice
mutat
term
introduc
prematur
termin
codon
caus
see
diagram
fig
assess
rnpinduc
indel
use
surveyor
assay
quantifi
sanger
sequenc
day
deliveri
fig
observ
indel
frequenc
confer
effici
rnp
deliveri
figur
show
effect
dose
durat
incub
edit
effici
increas
peptid
concentr
improv
edit
durat
incub
investig
edit
effici
rnp
anoth
target
select
locu
fig
achiev
greatest
indel
fig
also
test
rnp
design
cftr
exon
noncf
epithelia
fig
cftr
exon
site
common
mutat
peptid
achiev
similar
indel
illustr
difficulti
deliv
macromolecular
cargo
hae
transfect
rnp
three
commerci
lipofect
reagent
observ
edit
two
differ
cftr
loci
supplementari
fig
investig
util
shuttl
peptid
vivo
deliv
nucleartarget
gfp
protein
airway
adult
balbc
mice
nasal
instil
select
peptid
base
perform
hae
fig
administ
gfp
twice
h
period
approxim
h
final
treatment
mice
euthan
gfp
distribut
evalu
observ
widespread
nuclear
gfp
signal
within
larg
small
airway
epithelia
fig
coloc
confirm
gfp
deliv
ciliat
noncili
secretori
club
cell
fig
c
repres
two
predomin
surfac
cell
type
murin
larg
fig
small
fig
airway
noncili
club
cell
wellcharacter
progenitor
cell
distal
lung
observ
occasion
gfp
cell
coloc
spc
marker
alveolar
type
ii
cell
fig
white
arrow
transduct
effici
larg
airway
mean
se
one
two
dose
respect
small
airway
deliveri
effici
mean
se
one
two
dose
respect
fig
test
feasibl
rnpmediat
gene
edit
vivo
use
rosamtmg
mice
cell
express
membraneloc
tdtomato
fluoresc
delet
tdtomato
cassett
crelox
recombin
dual
ca
rnp
cleavag
result
express
cell
membraneloc
gfp
fig
due
absenc
protospac
adjac
motif
pam
loxp
region
previou
posit
outcom
use
crelox
report
next
evalu
rnp
vivo
deliv
rnp
target
loxp
site
airway
rosamtmg
mice
use
peptid
mice
receiv
one
rnp
dose
per
day
two
consecut
day
see
fig
one
week
follow
second
dose
local
gfpexpress
edit
cell
lung
tissu
similar
gfp
protein
deliveri
observ
widespread
rnpmediat
edit
epitheli
cell
larg
fig
c
small
airway
fig
ciliat
noncili
cell
express
gfp
fig
arrow
arrowhead
confirm
edit
two
predomin
surfac
cell
type
distal
lung
observ
occasion
coloc
gfp
surfact
protein
c
spc
marker
alveolar
type
ii
cell
fig
arrow
follow
deliveri
rnp
alon
edit
larg
small
airway
fig
h
edit
effici
larg
airway
mean
se
small
airway
edit
effici
mean
se
fig
next
ask
whether
shuttl
peptidemedi
protein
deliveri
associ
acut
toxic
applic
alon
gfp
protein
effect
hae
viabil
assess
lactat
dehydrogenas
ldh
releas
supplementari
fig
address
vivo
toxic
deliv
two
dose
rnp
peptid
alon
phosphatebuff
salin
pb
mice
describ
day
post
deliveri
quantifi
inflammatori
cell
infiltr
bronchoalveolar
lavag
bal
total
differenti
cell
count
lung
tissu
cytokin
chemokin
messeng
rna
mrna
abund
histopatholog
evalu
observ
signific
differ
bal
cell
count
neutrophil
macrophag
abund
pbstreat
anim
receiv
alon
rnp
fig
histopatholog
score
demonstr
evid
increas
pulmonari
inflamm
injuri
group
fig
transient
increas
chemokin
cc
motif
ligand
mrna
observ
rnp
treatment
group
day
deliveri
supplementari
fig
find
resolv
day
investig
cargo
fate
lung
deposit
screen
shuttl
peptid
deliveri
firefli
luciferas
protein
hae
supplementari
fig
select
peptid
effect
vitro
one
hour
luciferas
protein
deliveri
airway
balbc
mice
peptid
measur
luciferas
distribut
use
bioluminesc
imag
bioluminesc
local
nasal
pulmonari
tissu
consist
protein
retent
respiratori
tract
supplementari
fig
optim
pam
sequenc
absent
loxp
region
rosamtmg
mice
nevertheless
test
rnp
deliveri
target
cttc
motif
loxp
sequenc
see
fig
success
use
suboptim
cttc
pam
previous
use
deliv
rnp
achiev
edit
larg
fig
c
small
airway
fig
epithelia
distribut
similar
observ
rnp
ciliat
noncili
cell
type
edit
fig
distal
lung
observ
occasion
coloc
gfp
spc
indic
edit
alveolar
type
ii
cell
fig
edit
effici
larg
airway
mean
se
small
airway
edit
effici
mean
se
fig
great
interest
protein
nucleic
acidbas
therapeut
airway
diseas
deliveri
respiratori
epitheli
cell
remain
exceedingli
challeng
sever
viral
nonvir
nanoparticl
formul
develop
address
deliveri
none
advanc
widespread
clinic
util
viral
vector
overcom
deliveri
complex
biolog
genet
payload
may
exceed
capac
vector
nonvir
dna
deliveri
approach
also
use
airway
epithelia
remain
ineffici
may
elicit
inflammatori
respons
follow
aerosol
lead
endosom
lysosom
use
ca
rnp
rather
code
mrna
dna
offer
advantag
therapeut
context
limit
genom
exposur
edit
machineri
decreas
offtarget
rel
good
agreement
studi
suggest
engin
peptid
confer
effect
nontox
protein
rnp
transfer
airway
epithelia
vitro
vivo
observ
optim
peptid
twice
effici
deliv
rnp
primari
nk
cell
find
encourag
test
welldifferenti
epitheli
cell
follow
applic
shuttl
peptid
gfp
protein
ca
rnp
apic
surfac
hae
rapid
widespread
entri
observ
ciliat
noncili
goblet
cell
remark
protein
deliveri
also
confirm
human
tracheal
tissu
explant
achiev
robust
deliveri
hardtotransduc
nk
cell
primari
immun
cell
cultur
suspens
airway
cell
welldifferenti
epithelium
suggest
peptid
technolog
repres
advanc
target
difficulttotransduc
human
cell
excit
discov
shuttl
peptid
could
transfer
recombin
protein
gfp
luciferas
ca
rnp
form
use
streptococcu
pyogen
acidaminococcu
speci
mous
airway
vivo
deliveri
strategi
offer
promis
gene
edit
may
allow
modif
access
progenitor
cell
type
airway
alveolar
club
cell
cell
alveolar
type
ii
cell
access
lumin
furthermor
proxim
airway
basal
progenitor
cell
may
membran
extens
reach
airway
addit
repeat
administr
appear
feasibl
shuttl
peptid
also
address
ineffici
toxic
nonvir
system
peptid
quickli
deliveri
confin
epithelia
respiratori
tract
simplic
peptid
design
offer
altern
small
molecul
viral
vector
peptid
provid
rapid
protein
deliveri
rapid
onset
effect
demonstr
rnpmediat
gene
edit
may
offer
therapeut
opportun
remov
aberr
splice
site
one
exampl
cf
studi
examin
relationship
percentag
cell
express
cftr
transepitheli
rel
good
agreement
suggest
correct
cftr
cell
restor
secret
near
wildtyp
level
edit
activ
within
rang
achiev
studi
addit
challeng
remain
attain
therapeut
end
includ
method
codeliveri
homolog
recombin
templat
identif
altern
crispr
nucleas
base
evalu
larger
anim
highest
edit
observ
epitheli
cell
use
rnp
achiev
limit
edit
interestingli
vivo
edit
similar
direct
comparison
nucleas
activ
challeng
multipl
factor
may
influenc
observ
edit
effici
inde
intrins
activ
nucleas
may
differ
deliveri
effici
also
greatli
influenc
efficaci
share
similar
size
kda
kda
major
characterist
like
influenc
deliveri
net
neg
charg
densiti
contribut
respect
grna
type
v
crispr
protein
use
simpl
crrna
crispr
rna
nucleotid
nt
type
ii
crispr
protein
requir
crrna
tracrrna
transactiv
crrna
nt
complex
deliv
use
lipid
electropor
cell
respons
transfect
shorter
crrna
appear
reduc
effici
use
dna
deliveri
method
exampl
includ
dna
carrier
electropor
solut
increas
crrna
length
improv
deliveri
contrast
observ
ad
longer
crnatracrrna
rnp
protein
cargo
reduc
shuttl
peptidemedi
protein
deliveri
supplementari
fig
addit
deliveri
effici
grna
choic
greatli
influenc
nucleas
activ
ontarget
offtarget
activ
individu
grna
vari
note
indel
observ
rosamtmg
mice
base
fluorophor
convers
like
underestim
singl
dna
doublestrand
break
loxp
site
would
caus
fluorophor
switch
final
pam
differ
design
grna
possibl
compar
nucleas
activ
use
grna
target
sequenc
interestingli
cleav
loxp
sequenc
cttc
pam
loxp
use
open
possibl
target
creloxbas
report
effect
pam
suboptim
vivo
activ
improv
use
differ
grna
tttv
permiss
engin
potenti
limit
shuttl
peptid
deliveri
cell
membran
injuri
result
endosomolyt
sequenc
critic
dose
dose
interv
establish
specif
applic
toxic
may
minim
repeat
administr
possibl
result
initi
toxic
studi
fig
encourag
despit
evid
shortterm
toxic
futur
studi
address
immunogen
specif
therapeut
investig
also
requir
establish
relationship
uniqu
physicochem
properti
peptid
sequenc
provid
specif
molecular
interact
depend
upon
natur
protein
cargo
target
cell
note
gfp
protein
ca
rnp
deliveri
airway
mice
heterogen
improv
effici
shuttl
peptid
deliveri
respiratori
tract
might
achiev
screen
new
engin
peptid
test
formul
aerosol
deliveri
summari
shuttl
peptid
platform
success
deliv
sever
protein
cargo
human
primari
nk
airway
epitheli
cell
achiev
clinic
relev
genom
edit
mous
airway
without
sign
shortterm
toxic
technolog
repres
versatil
deliveri
strategi
therapi
address
biolog
question
provid
breakthrough
approach
hardtotransduc
cell
type
may
serv
platform
design
opportun
cargo
includ
therapeut
antibodi
peptid
nucleartarget
egfp
gfpnl
express
bacteria
escherichia
coli
purifi
previous
nucleas
catalog
idt
coralvil
ia
catalog
feldan
therapeut
quebec
qc
nucleas
protein
catalog
idt
coralvil
ia
catalog
feldan
therapeut
quebec
qc
firefli
luciferas
catalog
promega
madison
wi
purchas
provid
feldan
therapeut
peptid
synthet
gl
biochem
shanghai
china
tracrrna
purchas
idt
catalog
specif
crrna
synthes
idt
coralvil
ia
sigmaaldrich
corpor
st
loui
mo
lyophil
peptid
resuspend
pb
kept
frozen
gfpnl
protein
formul
mgml
pb
kept
frozen
ca
protein
luciferas
kept
frozen
manufactur
buffer
grna
stock
frozen
dilut
use
prior
experi
shuttl
peptid
gfpnl
luciferas
grna
ca
protein
thaw
kept
ice
primari
airway
epithelia
isol
human
porcin
donor
trachea
bronchi
grown
interfac
collagenco
costar
transwel
polycarbon
filter
surfac
area
cultur
maintain
media
supplement
ultros
g
usg
follow
antibiot
penicillin
uml
streptomycin
cultur
cell
maintain
epitheli
cell
well
differenti
week
old
resist
nk
cell
kindli
provid
green
cross
labcel
south
korea
cultiv
nk
mac
media
contain
human
serum
shuttl
peptid
dilut
obtain
desir
final
concentr
volum
pb
ad
achiev
remain
volum
minu
volum
cargo
volum
protein
cargo
gfpnl
luciferas
ad
reach
desir
concentr
solut
mix
ad
cell
deliv
intranas
mice
rnp
prepar
combin
respect
recombin
nucleas
protein
grna
pb
incub
room
temperatur
min
deliveri
twopart
crispr
rna
crrna
tracrrna
first
combin
pb
denatur
min
renatur
room
temperatur
form
rna
duplex
concentr
ca
rnp
complex
formul
concentr
final
volum
shuttl
peptid
solut
formul
pb
concentr
volum
mix
ca
rnp
mixtur
solut
mix
ad
cell
deliv
intranas
mice
nk
cell
centrifug
min
g
wash
warm
pb
resuspend
concentr
cellsml
five
hundr
thousand
nk
cell
distribut
ml
tube
centrifug
min
g
supernat
remov
cell
resuspend
mixtur
contain
peptid
ca
rnp
crrna
cell
wash
transfer
plate
nk
mac
media
supplement
human
serum
incub
h
tracheal
tissu
deem
unsuit
lung
transplant
use
excis
tissu
bisect
longitudin
expos
lumin
surfac
cut
piec
tissu
piec
place
lumen
side
onto
costar
polystyren
cultur
plate
explant
immers
airway
cell
cultur
media
usg
antibiot
penicillin
uml
streptomycin
transduc
tissu
volum
shuttl
peptid
formul
nucleartarget
gfp
protein
appli
apic
surfac
explant
h
formul
remov
rins
three
time
pb
explant
incub
overnight
h
post
deliveri
explant
fix
paraformaldehyd
sucros
protect
embed
oct
final
concentr
nucleas
rna
rnp
prepar
respect
rnp
combin
desir
concentr
shuttl
peptid
incub
min
addit
cell
volum
mixtur
left
cell
surfac
time
indic
text
figur
legend
grna
use
list
supplementari
tabl
apic
surfac
welldifferenti
airway
epithelia
grown
interfac
wash
twice
pb
volum
shuttl
peptid
formul
nucleartarget
gfp
protein
appli
apic
surfac
incub
indic
time
incub
materi
remov
apic
surfac
wash
thrice
pb
live
cell
gfp
fluoresc
visual
invert
tissu
microscop
olympu
olympu
scientif
solut
america
corp
waltham
mean
fluoresc
intens
obtain
use
spectramax
fluoresc
reader
molecular
devic
san
jose
ca
luciferas
express
monitor
noninvas
use
bioluminesc
one
hour
follow
deliveri
solut
contain
luciferas
protein
combin
peptid
volum
intranas
mice
receiv
g
bodi
weight
mgml
pb
deliv
intraperiton
dluciferin
xenogen
alameda
ca
anesthet
isofluran
inhal
approxim
min
luciferin
inject
anim
imag
use
xenogen
ccd
camera
imag
data
analyz
signal
intens
quantifi
use
xenogen
live
imag
softwar
express
level
normal
subtract
naiv
untreat
mice
three
day
post
transduct
genom
dna
isol
use
quickextract
catalog
epicent
accord
manufactur
instruct
pcr
amplif
genom
dna
perform
use
ng
genom
dna
specif
design
forward
revers
primer
supplementari
tabl
kapa
dna
polymeras
kapa
biosystem
pcr
product
purifi
ng
purifi
dna
denatur
reanneal
presenc
neb
restrict
enzym
buffer
thermocycl
reanneal
dna
mix
enhanc
surveyor
nucleas
idt
accord
manufactur
instruct
incub
min
separ
trisborateedta
gel
dna
band
visual
use
sybr
gold
stain
thermo
scientif
endonucleas
also
use
detect
ontarget
crisprca
genomeedit
event
cultur
cell
briefli
genom
dna
target
cell
amplifi
pcr
pcr
product
denatur
reanneal
allow
heteroduplex
format
wildtyp
dna
crisprcasmut
dna
recogn
cleav
mismatch
dna
use
digest
heteroduplex
result
cleav
fulllength
pcr
product
visual
gel
electrophoresi
assay
perform
use
neb
catalog
deliveri
crisprca
complex
cell
lyse
highfidel
dna
polymeras
neb
catalog
laboratori
addit
cell
incub
min
follow
deactiv
min
plate
briefli
centrifug
collect
liquid
bottom
well
fifti
microlit
pcr
sampl
analyz
condit
pcr
sampl
heat
min
slowli
min
cool
room
temperatur
pcr
product
separ
agaros
gel
confirm
amplif
fifteen
microlit
reaction
incub
nucleas
min
immedi
entir
reaction
volum
run
appropri
gel
load
buffer
agaros
gel
biorad
imagelabtm
softwar
version
use
quantifi
rel
signal
intens
band
directli
gel
quantif
indel
perform
use
equat
b
c
b
c
intens
undigest
pcr
product
b
c
intens
cleav
sum
three
band
interest
one
gene
target
two
cleavag
product
given
lane
correspond
signal
cleavag
product
band
found
neg
control
pcr
product
amplifi
surveyor
assay
also
clone
psmart
clone
vector
lucigen
purifi
dna
phosphoryl
pnk
min
ligat
dna
ligat
perform
accord
manufactur
protocol
ligat
mixtur
transform
cell
plate
lb
ampicillin
plate
least
coloni
grown
plasmid
prep
sanger
sequenc
function
bioscienc
madison
wi
epitheli
cell
tracheal
explant
lung
tissu
prepar
histolog
examin
immunohistochemistri
cellular
marker
fixat
paraformaldehyd
sucros
protect
cryoembed
oct
case
cell
tissu
embed
paraffin
routin
histolog
tissu
section
stain
hematoxylin
eosin
detail
descript
method
local
protein
express
larg
small
airway
provid
coloc
gfpnl
protein
membraneassoci
gfp
express
rosamtmg
mice
marker
specif
cell
type
section
first
incub
primari
antibodi
acetyl
dilut
catalog
cell
signal
dilut
catalog
invitrogen
spc
dilut
catalog
thermo
fisher
follow
incub
alexa
fluor
phalloidin
dilut
catalog
invitrogen
mount
vectashield
dapi
vector
lab
section
imag
confoc
microscopi
use
leica
multiphoton
confoc
microscop
leica
buffalo
grove
il
three
five
mice
male
femal
analyz
per
time
point
per
experiment
condit
cell
lift
transwel
support
appli
accumax
catalog
innov
cell
technolog
cell
surfac
h
cell
pellet
resuspend
pb
fetal
calf
serum
strain
nylon
mesh
filter
gfp
cell
enumer
use
becton
dickinson
facscan
fac
calib
lsrii
bd
bioscienc
spark
md
shuttl
peptid
protein
cargo
formul
deliv
male
femal
balbc
mice
intranas
deliveri
transduc
epithelia
airway
volum
shuttl
peptid
formul
nucleartarget
gfp
protein
use
genom
edit
volum
shuttl
peptid
formul
nucleas
rna
rnp
prepar
use
mice
anesthet
ketaminexylazin
intramuscularli
mgkg
mgkg
xylazin
indic
amphiphil
peptid
protein
cargo
introduc
intranas
studi
rosamtmg
mice
jackson
lab
stock
epitheli
cell
sheet
fix
paraformaldehyd
wash
pb
costar
filter
insert
cut
plastic
support
place
onto
microscop
slide
mount
vectashield
mount
media
dapi
use
leica
confoc
microscop
imag
six
random
field
filter
captur
magnif
manual
count
perform
enumer
blue
nuclei
gfp
cell
epitheli
cell
within
six
field
count
determin
percentag
posit
cell
numer
number
gfp
cell
denomin
total
number
cell
six
magnif
field
count
epitheli
sheet
lung
tissu
fix
paraformaldehyd
perfus
cryopreserv
tissu
place
cryomold
en
bloc
ventral
side
ensur
uniform
consist
section
lobe
tissu
section
thick
collect
section
studi
depth
section
lung
lobe
visibl
block
section
provid
area
contain
small
airway
next
section
collect
deeper
block
region
consist
contain
larg
airway
monopodi
branch
consecut
section
collect
cell
count
coloc
use
immunocytochemistri
follow
criteria
use
quantifi
gfp
airway
cell
mous
lung
exhibit
monopodi
airway
branch
airway
lack
cartilag
gland
anatom
defin
bronchiol
accordingli
anatom
segreg
bronchiolar
airway
two
group
base
morpholog
distinct
sitess
right
left
main
bronchu
categor
larg
airway
small
bronchiol
airway
defin
termin
airway
similar
size
measur
lumen
area
use
imagej
trace
along
lumen
circumfer
measur
lumen
length
width
small
airway
studi
lumen
area
lengthtowidth
ratio
epithelia
small
airway
one
lobe
count
area
count
total
number
cell
epitheli
layer
airway
use
dapi
nuclear
stain
count
total
number
gfp
cell
airway
total
number
epitheli
cell
gfp
cell
larg
airway
count
use
method
small
airway
day
post
instil
pb
peptid
alon
rnp
mice
euthan
inhal
follow
cervic
disloc
chest
open
lung
lavag
situ
via
tube
insert
expos
trachea
pressur
cm
use
lavag
lung
total
ml
steril
salin
collect
wash
immedi
pool
place
ice
bal
cell
count
perform
use
hemocytomet
differenti
cell
count
perform
cytospin
follow
cell
stain
diffquik
stain
set
siemen
healthcar
diagnost
newark
de
quantif
cellular
infiltr
lung
tissu
pathologist
perform
quantif
mask
group
highresolut
digit
imag
field
lung
tissu
collect
number
respect
immun
cell
enumer
per
imag
field
standard
per
imag
area
statist
analysi
perform
use
prism
graphpad
softwar
la
jolla
ca
usa
test
statist
signific
place
p
tissu
evalu
acvp
board
pathologist
score
use
post
examin
mask
four
mice
male
femal
analyz
per
time
point
per
experiment
condit
lung
tissu
homogen
trizol
total
rna
isol
use
directzol
rna
miniprep
kit
zymo
research
irvin
ca
dnase
treatment
step
includ
two
hundr
nanogram
total
rna
use
templat
firststrand
complementari
dna
cdna
synthesi
result
cdna
dilut
subject
amplif
select
cytokin
chemokin
gene
realtim
quantit
pcr
use
power
sybr
green
pcr
master
mix
appli
biosystem
primer
sequenc
list
supplementari
tabl
averag
valu
duplic
gene
use
calcul
rel
abund
transcript
normal
present
rel
normal
level
primer
use
previous
primari
airway
epitheli
cell
cultur
three
noncf
human
donor
transduc
peptid
alon
coincub
gfpnl
protein
volum
min
apic
surfac
wash
basolater
media
collect
indic
time
point
post
transfect
ldh
cytotox
assay
kit
cayman
chemic
use
measur
ldh
level
apic
surfac
wash
basolater
media
percentag
toxic
viabil
comput
base
ldh
level
data
normal
cell
treat
dulbecco
modifi
eagl
medium
dmem
alon
neg
control
cell
treat
dmem
contain
triton
posit
control
apic
basolater
surfac
min
day
analysi
varianc
anova
tukey
multipl
comparison
test
twoway
anova
dunnett
multipl
comparison
test
use
analyz
differ
mean
valu
group
result
express
mean
se
p
valu
consid
signific
primari
airway
epithelia
vivo
studi
approv
institut
review
board
univers
iowa
anim
procedur
approv
univers
iowa
institut
anim
care
use
committe
iacuc
accord
nation
institut
health
guidelin
nk
cell
studi
approv
nation
research
council
research
ethic
board
canada
